Dining upgrades a la 'cart'
Profile: On the side of seniors
Dementia-friendly ways to worship
By Jackie Vance
by Shelly Mesure
By Gary Tetz
Drugmakers Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LCC will pay up to $109 million in a settlement over an alleged scheme to provide doctors with free units of its knee-injection drug Hyalgan in return for purchase of the treatment.